<VariationArchive VariationID="1071422" VariationName="NM_003664.5(AP3B1):c.1619dup (p.Ala541fs)" VariationType="Duplication" Accession="VCV001071422" Version="8" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2019-10-02" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1060449" VariationID="1071422">
      <GeneList>
        <Gene Symbol="AP3B1" FullName="adaptor related protein complex 3 subunit beta 1" GeneID="8546" HGNC_ID="HGNC:566" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q14.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="78000522" stop="78294698" display_start="78000522" display_stop="78294698" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="77298149" stop="77590527" display_start="77298149" display_stop="77590527" Strand="-" />
          </Location>
          <OMIM>603401</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_003664.5(AP3B1):c.1619dup (p.Ala541fs)</Name>
      <CanonicalSPDI>NC_000005.10:78141173:CCC:CCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>5q14.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="78141173" stop="78141174" display_start="78141173" display_stop="78141174" variantLength="1" positionVCF="78141173" referenceAlleleVCF="T" alternateAlleleVCF="TC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="77436997" stop="77436998" display_start="77436997" display_stop="77436998" variantLength="1" positionVCF="77436997" referenceAlleleVCF="T" alternateAlleleVCF="TC" />
      </Location>
      <ProteinChange>A492fs</ProteinChange>
      <ProteinChange>A541fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_170" sequenceAccession="LRG_170">
            <Expression>LRG_170:g.158531dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_170t1" sequenceAccession="LRG_170t1">
            <Expression>LRG_170t1:c.1619dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.78141176dup" Assembly="GRCh38">
            <Expression>NC_000005.10:g.78141176dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.77437000dup" Assembly="GRCh37">
            <Expression>NC_000005.9:g.77437000dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007268.1" sequenceAccession="NG_007268" sequenceVersion="1" change="g.158531dup">
            <Expression>NG_007268.1:g.158531dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001271769.2" sequenceAccession="NM_001271769" sequenceVersion="2" change="c.1472dup">
            <Expression>NM_001271769.2:c.1472dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001258698.1" sequenceAccession="NP_001258698" sequenceVersion="1" change="p.Ala492fs">
            <Expression>NP_001258698.1:p.Ala492fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003664.5" sequenceAccession="NM_003664" sequenceVersion="5" change="c.1619dup" MANESelect="true">
            <Expression>NM_003664.5:c.1619dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003655.3" sequenceAccession="NP_003655" sequenceVersion="3" change="p.Ala541fs">
            <Expression>NP_003655.3:p.Ala541fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="603401.0003" DB="OMIM" />
        <XRef Type="rs" ID="1753129765" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003664.5(AP3B1):c.1619dup (p.Ala541fs) AND Hermansky-Pudlak syndrome 2" Accession="RCV001383893" Version="7">
        <ClassifiedConditionList TraitSetID="1768">
          <ClassifiedCondition DB="MedGen" ID="C1842362">Hermansky-Pudlak syndrome 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-02-18" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-02-18" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2019-10-02" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">14566336</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16507770</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23403622</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1768" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2034" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hermansky-Pudlak syndrome 2</ElementValue>
                <XRef ID="MONDO:0011997" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Platelet defects and oculocutaneous albinism</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HPS2</ElementValue>
                <XRef Type="MIM" ID="608233" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hermansky-Pudlak syndrome (HPS) is characterized by oculocutaneous albinism, a bleeding diathesis, and, in some individuals, pulmonary fibrosis, granulomatous colitis, or immunodeficiency. Ocular findings include reduced iris pigment with iris transillumination, reduced retinal pigment, foveal hypoplasia with significant reduction in visual acuity (usually in the range of 20/50 to 20/400), nystagmus, and increased crossing of the optic nerve fibers. Hair color ranges from white to brown; skin color ranges from white to olive and is usually a shade lighter than that of other family members. The bleeding diathesis can result in variable bruising, epistaxis, gingival bleeding, postpartum hemorrhage, colonic bleeding, and prolonged bleeding with menses or after tooth extraction, circumcision, and other surgeries. Pulmonary fibrosis, a restrictive lung disease, typically causes symptoms in the early thirties and can progress to death within a decade. Granulomatous colitis is severe in about 15% of affected individuals. Neutropenia and/or immune defects occur primarily in individuals with pathogenic variants in AP3B1 and AP3D1.</Attribute>
                <XRef ID="NBK1287" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9435" />
                <XRef ID="9435" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301464</ID>
                <ID Source="BookShelf">NBK1287</ID>
              </Citation>
              <XRef ID="183678" DB="Orphanet" />
              <XRef ID="79430" DB="Orphanet" />
              <XRef ID="C1842362" DB="MedGen" />
              <XRef ID="MONDO:0011997" DB="MONDO" />
              <XRef Type="MIM" ID="608233" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="26937" SubmissionDate="2019-09-30" DateLastUpdated="2019-10-02" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="603401.0003_HERMANSKY-PUDLAK SYNDROME 2" title="AP3B1, 1-BP INS, 1618G_HERMANSKY-PUDLAK SYNDROME 2" />
        <ClinVarAccession Accession="SCV000026937" DateUpdated="2019-10-02" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with Hermansky-Pudlak syndrome-2 (HPS2; 608233), Clark et al. (2003) identified compound heterozygosity for mutations in the AP3B1 gene. One mutation was a 1-bp insertion (G) at nucleotide 1618 in exon 15, resulting in a frameshift and premature stop codon at position 565. The other mutation was a T-to-C transition at position +6 of the splice site in intron 14 (603401.0004), leading to a 39-bp insertion and the introduction of a stop codon at amino acid 496.</Attribute>
              <Citation>
                <ID Source="PubMed">14566336</ID>
              </Citation>
              <XRef DB="OMIM" ID="608233" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AP3B1" />
          </GeneList>
          <Name>AP3B1, 1-BP INS, 1618G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 1618G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603401.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HERMANSKY-PUDLAK SYNDROME 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3108852" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="4855529|MedGen:C1842362" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001583215" DateUpdated="2024-02-14" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16507770</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23403622</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14566336</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ala541Serfs*25) in the AP3B1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AP3B1 are known to be pathogenic (PMID: 16507770, 23403622). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Hermansky-Pudlak syndrome (PMID: 14566336). ClinVar contains an entry for this variant (Variation ID: 1071422). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AP3B1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.77436997_77436998insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1842362" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="26937" TraitType="Disease" MappingType="Name" MappingValue="HERMANSKY-PUDLAK SYNDROME 2" MappingRef="Preferred">
        <MedGen CUI="C1842362" Name="Hermansky-Pudlak syndrome 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3108852" TraitType="Disease" MappingType="XRef" MappingValue="C1842362" MappingRef="MedGen">
        <MedGen CUI="C1842362" Name="Hermansky-Pudlak syndrome 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

